Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.280
+0.010 (0.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cabaletta Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-115.86-67.68-52.98-46.29-33.34
Upgrade
Depreciation & Amortization
1.711.431.180.730.35
Upgrade
Loss (Gain) From Sale of Investments
-1.53-1.22-0.220.060.12
Upgrade
Stock-Based Compensation
19.4711.346.95.84.39
Upgrade
Other Operating Activities
6.382.483.04--
Upgrade
Change in Accounts Payable
1.011.68-0.030.980.56
Upgrade
Change in Other Net Operating Assets
0.6-1.57-4.274.611.15
Upgrade
Operating Cash Flow
-88.22-53.55-46.38-34.11-26.77
Upgrade
Capital Expenditures
-2.21-0.69-2.45-1.17-0.64
Upgrade
Investment in Securities
49.5-21.76-24.767.17-7.35
Upgrade
Investing Cash Flow
47.29-22.45-27.226-7.98
Upgrade
Long-Term Debt Repaid
-0.9----
Upgrade
Net Debt Issued (Repaid)
-0.9----
Upgrade
Issuance of Common Stock
12.57187.6332.9848.90.17
Upgrade
Other Financing Activities
-----0.19
Upgrade
Financing Cash Flow
11.68187.6332.9848.9-0.02
Upgrade
Foreign Exchange Rate Adjustments
-0.02----
Upgrade
Net Cash Flow
-29.28111.63-40.6220.79-34.78
Upgrade
Free Cash Flow
-90.43-54.24-48.83-35.28-27.41
Upgrade
Free Cash Flow Per Share
-1.84-1.32-1.66-1.37-1.18
Upgrade
Cash Interest Paid
0.75----
Upgrade
Levered Free Cash Flow
-54.51-30.41-29.25-17.82-15.53
Upgrade
Unlevered Free Cash Flow
-54.04-30.41-29.25-17.82-15.53
Upgrade
Change in Net Working Capital
-5.21-4.171.04-5.75-1.51
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q